WFA
DFTX

Wipfli Financial Advisors’s Definium Therapeutics DFTX Stock Holding History

Wipfli Financial Advisors’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$0 Buy
+6
New +$58 ﹤0.01% 2594

Other funds holding DFTX

DCI
Data Collective IV Palo Alto, California $55.9M AUM 49.14% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
BB
Busey Bank Urbana, Illinois $3.68B AUM 26.6% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Wipfli Financial Advisors's DFTX Position: Q3 2022 in Review

Wipfli Financial Advisors opened a new position in Definium Therapeutics (DFTX) in Q3 2022: 6 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #2594 among its holdings.

101 funds tracked by Wall St. Rank hold DFTX as of Q3 2022.

  • Wipfli Financial Advisors held 6 shares of Definium Therapeutics worth $0 as of Q3 2022.
  • Definium Therapeutics was a new Wipfli Financial Advisors position in Q3 2022.
  • Definium Therapeutics made up ﹤0.01% of Wipfli Financial Advisors's portfolio in Q3 2022, its #2594 holding.
  • 101 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2022.

Based on Wipfli Financial Advisors's 13F filing for Q3 2022, filed 26 Oct 2022.